Pristiq

DRUG5 trials

Sponsors

The Medical Research Network, Luye Pharma Group Ltd.

Conditions

Major DepressionMajor Depressive DisorderSocial Anxiety Disorder

Phase 1

Safety, Tolerability and Pharmacokinetics Study of LY03005

CompletedNCT02055300

Luye Pharma Group Ltd.Major Depressive Disorder

Start: 2014-02-28End: 2014-08-31Updated: 2014-11-10

Pilot BA Study of New LY03005 vs Pristiq

CompletedNCT02988024

Luye Pharma Group Ltd.Major Depression

Start: 2016-12-07End: 2016-12-28Updated: 2017-03-20

Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®

CompletedNCT03357796

Luye Pharma Group Ltd.Major Depressive Disorder

Start: 2017-11-27End: 2017-12-22Updated: 2018-01-04

A Study of LY03005 vs Pristiq

CompletedNCT03733574

Luye Pharma Group Ltd.Major Depressive Disorder

Start: 2018-06-19End: 2018-07-26Updated: 2018-11-09

Phase 4

12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder

CompletedNCT01316302

The Medical Research NetworkSocial Anxiety Disorder

Start: 2011-04-30End: 2012-12-31Updated: 2016-10-17